Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/95626
Title: Emerging roles of angiopoietin-like 4 in human cancer
Authors: Tan, Ming Jie
Teo, Ziqiang
Sng, Ming Keat
Zhu, Pengcheng
Tan, Nguan Soon
Keywords: DRNTU::Science::Biological sciences::Molecular biology
Issue Date: 2012
Source: Tan, M. J., Teo, Z., Sng, M. K., Zhu, P., & Tan, N. S. (2012). Emerging Roles of Angiopoietin-like 4 in Human Cancer. Molecular Cancer Research, 10(6), 677-688.
Series/Report no.: Molecular cancer research
Abstract: Angiopoietin-like 4 (ANGPTL4) is best known for its role as an adipokine involved in the regulation of lipid and glucose metabolism. The characterization of ANGPTL4 as an adipokine is largely due to our limited understanding of the interaction partners of ANGPTL4 and how ANGPTL4 initiates intracellular signaling. Recent findings have revealed a critical role for ANGPTL4 in cancer growth and progression, anoikis resistance, altered redox regulation, angiogenesis, and metastasis. Emerging evidence suggests that ANGPTL4 function may be drastically altered depending on the proteolytic processing and posttranslational modifications of ANGPTL4, which may clarify several conflicting roles of ANGPTL4 in different cancers. Although the N-terminal coiled-coil region of ANGPTL4 has been largely responsible for the endocrine regulatory role in lipid metabolism, insulin sensitivity, and glucose homeostasis, it has now emerged that the COOH-terminal fibrinogen-like domain of ANGPTL4 may be a key regulator in the multifaceted signaling during cancer development. New insights into the mechanistic action of this functional domain have opened a new chapter into the possible clinical application of ANGPTL4 as a promising candidate for clinical intervention in the fight against cancer. This review summarizes our current understanding of ANGPTL4 in cancer and highlights areas that warrant further investigation. A better understanding of the underlying cellular and molecular mechanisms of ANGPTL4 will reveal novel insights into other aspects of tumorigenesis and the potential therapeutic value of ANGPTL4.
URI: https://hdl.handle.net/10356/95626
http://hdl.handle.net/10220/8287
ISSN: 1557-3125(electronic)
DOI: 10.1158/1541-7786.MCR-11-0519
Rights: © 2012 American Association for Cancer Research. This is the author created version of a work that has been peer reviewed and accepted for publication by Molecular Cancer Research, American Association for Cancer Research. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: DOI: [http://dx.doi.org/10.1158/1541-7786.MCR-11-0519].
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SBS Journal Articles

Files in This Item:
File Description SizeFormat 
MCR-11-0519 (Final).pdf1.03 MBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 50

88
Updated on Mar 5, 2021

PublonsTM
Citations 50

80
Updated on Mar 3, 2021

Page view(s) 50

792
Updated on Mar 8, 2021

Download(s) 10

361
Updated on Mar 8, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.